ArticleOncology letters2018

Kadsurenone is a useful and promising treatment strategy for breast cancer bone metastases by blocking the PAF/PTAFR signaling pathway.

Tianhui Hou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.